Laurion Capital Management’s Pliant Therapeutics PLRX Stock Holding History

Laurion Capital Management’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$471K	Hold	412,796	–	–	0.01%	312
2026 Q1	$520K	Buy	412,796 +155,396	+60%	+$196K	0.02%	290
2025 Q4	$314K	Buy	+257,400	New	+$387K	0.01%	276
2024 Q3	–	Sell	-2,498,920	Closed	-$26.9M	–	532
2024 Q2	$26.9M	Sell	2,498,920 -975,824	-28%	-$12.6M	0.32%	58
2024 Q1	$51.8M	Sell	3,474,744 -108,823	-3%	-$1.8M	0.44%	49
2023 Q4	$64.9M	Buy	3,583,567 +397,056	+12%	+$6.04M	0.55%	50
2023 Q3	$55.3M	Buy	3,186,511 +27,941	+0.9%	+$484K	0.34%	69
2023 Q2	$57.2M	Buy	+3,158,570	New	+$74.8M	0.32%	65
2022 Q3	–	Sell	-470,601	Closed	-$3.77M	–	587
2022 Q2	$3.77M	Buy	+470,601	New	+$3.01M	0.06%	192

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Laurion Capital Management's PLRX Position: Q2 2026 in Review

Laurion Capital Management held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 412,796 shares worth $471K. The position accounts for 0.01% of the portfolio, ranked #312.

Laurion Capital Management first reported a position in PLRX in Q2 2022 and has held it in 9 quarters since. The position peaked at $64.9M in Q4 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Laurion Capital Management held 412,796 shares of Pliant Therapeutics worth $471K as of Q2 2026.
Laurion Capital Management left its Pliant Therapeutics share count unchanged in Q2 2026.
Pliant Therapeutics made up 0.01% of Laurion Capital Management's portfolio in Q2 2026, its #312 holding.
Laurion Capital Management first reported a position in Pliant Therapeutics in Q2 2022 and has held it in 9 quarters since.
Laurion Capital Management's Pliant Therapeutics position peaked at $64.9M in Q4 2023.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Laurion Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.